N/A
N=12
Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor
Dystonia · Tremor
Bottom Line
View on ClinicalTrials.gov: NCT04299087 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Cognitive Assessment Using MoCA Version 7.1 Scores — 25.45; 27 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- repetitive Transcranial Magnetic Stimulation (rTMS) (Device); Control group (Other)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Florida
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cognitive Assessment Using MoCA Version 7.1 Scores |
25.45; 27 | — |
Summary
The study will include subjects diagnosed with Dystonic Tremor (DT), Essential Tremor (ET), and healthy controls in the age range of 21-80 years. Electroencephalography (EEG) will be used as the primary outcome measure. Transcranial Magnetic Stimulation (TMS) will be used over the motor cortices or cerebellar cortices as an intervention that is expected to have short-term (less than an hour) electrophysiological effects.
Eligibility Criteria
Inclusion Criteria for Dystonia and/or tremor:
- Diagnosis of Dystonia and/or tremor according to the Consensus Statement of the Movement Disorders Society
Exclusion Criteria Dystonia and/or tremor:
- Pregnancy
- Active seizure disorder
- Presence of a metallic object such as a pacemaker, implants, metal rods, and hearing aid
- History of stroke
Inclusion Criteria for Healthy controls
- There is no history of any neurological disorders.
Exclusion Criteria for Healthy controls
- Pregnancy
- Any neurological disorders
- Presence of a metallic body in their brain
- History of stroke
Data sourced from ClinicalTrials.gov (NCT04299087). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.